4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-16-113920
Options or other derivatives
- Co-Chief Executive Officer acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
WEST MICHAEL D · Co-Chief Executive Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-04-07 | Grant or award : show line 1 in the form Option to Purchase Common Shares | +175,000 | $3.16 | 2026-04-06 | 175,000 | 175,000 | D |
| 2016-04-07 | Grant or award : show line 2 in the form Restricted Stock Units | +25,000 | 25,000 | 25,000 | D |
Loading xslF345X03/doc4.xml…